Data Exchange and Controlled Terminology in CDISC

生物制药相关,包括biotech和pharma,股票分析,工作内推,简历评估,职业规划,研发交流,FDA资讯等

版主: Tlexander

回复
Tlexander楼主
论坛点评
论坛点评
帖子: 2747
注册时间: 7月 22, 2022, 5:34 pm

Data Exchange and Controlled Terminology in CDISC

帖子 Tlexander楼主 »

Data exchange refers to the process of sharing data between different systems or organizations. In the context of clinical research, data exchange involves sharing data between different clinical trial systems, such as electronic data capture systems, clinical trial management systems, and statistical analysis software.

Data exchange can be challenging because different systems may use different data formats, structures, or terminologies. To address this challenge, CDISC has developed a set of standard data formats and terminologies that can be used to ensure that data is consistent and interoperable between different systems.

Controlled terminology is a key component of CDISC's standardization efforts. Controlled terminology refers to a standardized set of terms and definitions that are used to describe clinical trial data. CDISC provides a set of controlled terminologies that cover a range of areas, including medical conditions, laboratory tests, and adverse events.

By using standardized controlled terminology, clinical trial data can be easily understood and shared between different systems and organizations. This helps to ensure that data is accurate and consistent, and reduces the risk of errors or misinterpretation of data.

In summary, data exchange and controlled terminology are both important components of CDISC's efforts to standardize clinical trial data. By promoting the use of standard data formats and terminologies, CDISC aims to improve the efficiency and accuracy of clinical trials and facilitate data sharing between different systems and organizations.
回复

回到 “生物制药(Pharmaceutical)”